Amicus Therapeutics Inc.

NASDAQ: FOLD
Share price (1/14/26): $14.38
Market cap (1/14/26): $4.437 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Automatic shelf registration

Ownership Filter

Rosenberg Ellen

Clark David Michael

Campbell Bradley L

News Filter

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

Announces Third Quarter 2025 Financial Results and Corporate Updates

Announces Second Quarter 2025 Financial Results and Corporate Updates

Shareholder Vote Results, Financial Statements or Exhibits

Announces First Quarter 2025 Financial Results and Corporate Updates

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Confidential treatment order